Eli Lilly LLY
NYSE LLY
$1,306.89 +36.14 (+2.84%)
As of: Oct 22, 2026 · 3:59 PM EDT

Eli Lilly (LLY) Other Non-Current Liabilities (2009 - 2026)

Updated

Eli Lilly's Other Non-Current Liabilities came in at $7.34 billion for Q2 2026, up 29.2% from $5.68 billion a year earlier and up 38.9% from the prior quarter.

Analysis

Eli Lilly (LLY) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends

At the end of FY2025, Eli Lilly's Other Non-Current Liabilities was $5.88 billion, up 44.7% from FY2024.

  • Other Non-Current Liabilities has increased in each of the last three years, with a five-year compound annual growth rate of 8.9% (FY2020 to FY2025).
  • Going back by year, Other Non-Current Liabilities was $4.06 billion in FY2024 (+5.5%), $3.85 billion in FY2023 (+3.8%), $3.71 billion in FY2022 (-5.4%) and $3.92 billion in FY2021 (+2.1%).
  • The Q2 2026 figure represents the highest quarterly Other Non-Current Liabilities in data going back to Q2 2009.
  • Year-over-year, Other Non-Current Liabilities increased in seven of the last eight quarters, with growth averaging 30.3%.
  • The fastest year-over-year change in Other Non-Current Liabilities over five years came in Q2 2025 (growth of 62.6%), and the weakest in Q2 2023 (a decline of 6.4%).
  • Business Quant data shows LLY's Other Non-Current Liabilities at $5.29 billion (Q1 2026), $5.88 billion (Q4 2025) and $6.29 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Vertex Pharmaceuticals 135.25 Bn 107.26 Bn 2.84 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.81 Bn
Mar 31, 2026 9.37 Bn
Dec 31, 2025 9.85 Bn
Sep 30, 2025 10.07 Bn
Jun 30, 2025 8.03 Bn
Mar 31, 2025 7.66 Bn
Dec 31, 2024 7.54 Bn
Sep 30, 2024 6.12 Bn
Jun 30, 2024 5.97 Bn
Mar 31, 2024 6.46 Bn
Dec 31, 2023 6.09 Bn
Sep 30, 2023 5.37 Bn
Jun 30, 2023 5.28 Bn
Mar 31, 2023 5.66 Bn
Dec 31, 2022 5.53 Bn
Sep 30, 2022 5.49 Bn
Jun 30, 2022 5.34 Bn
Mar 31, 2022 5.69 Bn
Dec 31, 2021 5.56 Bn
Sep 30, 2021 5.52 Bn
API Access

Eli Lilly Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=LLY&period=max&api_key=YOUR_API_KEY